Diagnostic and treatment algorithm of the Japanese society of hepatology: A consensus-based practice guideline

Oncology

Volumn 78, Issue SUPPL. 1, 2010, Pages 78-86

  Izumi, Namiki ^a  

^a MUSASHINO RED CROSS HOSPITAL   (Japan)

Author keywords

Child Pugh; Hepatocellular carcinoma; JIS score; Radiofrequency ablation; Surgical resection

Indexed keywords

ALGORITHM; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; ECHOGRAPHY; HEPATITIS B; HEPATITIS C; HUMAN; JAPAN; LIVER CELL CARCINOMA; NONHUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW;

ALGORITHMS; CARCINOMA, HEPATOCELLULAR; DIAGNOSTIC IMAGING; GASTROENTEROLOGY; HUMANS; INTERNATIONAL AGENCIES; JAPAN; LIVER NEOPLASMS; SOCIETIES, MEDICAL;

EID: 77954504641     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000315234     Document Type: Review

References (17)

1. Kokudo N, Makuuchi M: Evidence-based clinical practice guidelines for hepatocellular carcinoma in Japan: the J-HCC guidelines. J Gastroenterology 2009; 44: 119-121.
2. Silva MA, Hegab B, Hyde C, et al: Needle tract seeding following biopsy of liver lesions in the diagnosis of hepatocellular cancer: a systemic review and meta-analysis. Gut 2008; 57: 1592-1596.
3. Stigliano R, Marelli L, Yu D, et al: Seeding following percutaneous diagnostic and therapeutic approaches for hepatocellular carcinoma. What is the risk and outcome? Seeding risk for percutaneous approach of HCC. Cancer Treat Rev 2007; 33: 437-447.
4. Suzuki M, Maeyama S, Takahashi H, et al: Strategy for hepatic hyperplastic nodules in heavy drinkers. Alcohol Clin Exp Res 2004; 28: 153S-158S.
5. Golfieri R, Coppola F, Fusco F, et al: Malignant progression of a small nodule: hypovascular 'early HCC' converted to hypervascular 'small HCC' within six months. Dig Liver Dis 2007; 39: 883-890.
6. Kudo M, Chung H, Osaki Y: Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score. J Gastroenterol 2003; 38: 207-215.
7. Kudo M, Chung H, Haji S, et al: Validation of a new prognostic staging system for hepatocellular carcinoma: the JIS score compared with the CLIP score. Hepatology 2004; 40: 1396-1405.
8. Vivarelli M, Guglielmi A, Ruzzenente A, et al: Surgical resection versus percutaneous radiofrequency ablation in the treatment of hepatocellular carcinoma on cirrhotic liver. Ann Surg 2004; 240: 102-107.
9. Ueno S, Sakoda M, Kubo F, et al: Surgical resection versus radiofrequency ablation for small hepatocellular carcinomas within Milan criteria. J Hepatobiliary Pancreat Surg 2009; 16: 359-366.
10. Hiraoka A, Horiike N, Yamashita Y, et al: Efficacy of radiofrequency ablation therapy compared to surgical resection in 164 patients in Japan with single hepatocellular carcinoma smaller than 3 cm along with report of complications. Hepatogastroenterology 2008; 55: 217-1214
11. Hasegawa K, Makuuchi M, Takayama T, et al: Surgical resection vs. percutaneous ablation for hepatocellular carcinoma: a preliminary report of the Japanese nationwide survey. J Hepatol 2008; 49: 589-594.
12. Kirikoshi H, Saito S, Yoneda M, et al: Outcome of transarterial chemoembolization monotherapy, and combination with percutaneous ethanol injection, or radiofrequency ablation therapy for hepatocellular carcinoma. Hepatol Res 2009; 39: 553-562.
13. Yang W, Chen MH, Wang MQ, et al: Combination therapy of radiofrequency ablation and transarterial chemoembolization in recurrent hepatocellular carcinoma after hepatectomy compared with single treatment. Hepatol Res 2009; 39: 231-240.
14. Kurokohchi K, Hosomi N, Yoshitake A, et al: Successful treatment of large-size advanced hepatocellular carcinoma by transarterial chemoembolization followed by the combination therapy of percutaneous ethanol-lipiodol injection and radiofrequency ablation. Oncol Res 2006; 16: 1067-1070.
15. Llovet JM, Bruix J: Molecular targeted therapies in hepatocellular carcinoma. Hepatology 2008; 48: 1312-1327.
16. Hoffmann K, Glimm H, Radeleff B, et al: Prospective, randomized double-blind, multicenter, phase III clinical study on transarterial chemoembolization (TACE) combined with Sorafenib versus TACE plus placebo in patients with hepatocellular cancer before liver transplantation - HeiLivCa. BMC Cancer 2008; 26: 349.
17. Kudo M: Hepatocellular carcinoma 2009 and beyond: from the surveillance to molecular targeted therapy. Oncology 2008; 75: 1-12.